Fig. 7From: The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapyBiodistribution and circulation of different nanoparticles in vivo. A Biodistribution of nanoparticles in vivo. B Ex-vivo images of the major organs. C The quantitative analysis of the fluorescence in the major organs and tumors. D Circulation lifetime of nanoparticles. *, P < 0.05; **, P < 0.01; ***, P < 0.001Back to article page